These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26220860)

  • 61. Comparison of gadofosveset-enhanced three-dimensional magnetic resonance angiography with digital subtraction angiography for lower-extremity peripheral arterial occlusive disease.
    Grijalba FU; Esandi MC
    Acta Radiol; 2010 Apr; 51(3):284-9. PubMed ID: 20105092
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium.
    Iezzi R; Soulez G; Thurnher S; Schneider G; Kirchin MA; Shen N; Pirovano G; Spinazzi A
    Eur J Radiol; 2011 Feb; 77(2):358-68. PubMed ID: 19679417
    [TBL] [Abstract][Full Text] [Related]  

  • 63. High spatial resolution magnetic resonance imaging of experimental cerebral venous thrombosis with a blood pool contrast agent.
    Spuentrup E; Wiethoff AJ; Parsons EC; Spangenberg P; Stracke CP
    Eur J Radiol; 2010 Jun; 74(3):445-52. PubMed ID: 19394183
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fat-suppressed, three-dimensional T1-weighted imaging using high-acceleration parallel acquisition and a dual-echo Dixon technique for gadoxetic acid-enhanced liver MRI at 3 T.
    Yoon JH; Lee JM; Yu MH; Kim EJ; Han JK; Choi BI
    Acta Radiol; 2015 Dec; 56(12):1454-62. PubMed ID: 25480475
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Contrast-enhanced whole-heart MR coronary angiography at 3.0 T using the intravascular contrast agent gadofosveset.
    Prompona M; Cyran C; Nikolaou K; Bauner K; Reiser M; Huber A
    Invest Radiol; 2009 Jul; 44(7):369-74. PubMed ID: 19554666
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnostic performance of gadobenate dimeglumine enhanced MR angiography of the iliofemoral and calf arteries: a large-scale multicenter trial.
    Thurnher S; Miller S; Schneider G; Ballarati C; Bongartz G; Herborn CU; Schoenberg S; Cova MA; Morana G; Niazi K; Iezzi R; Taupitz M; Bluemke DA; Kreitner KF; Kirchin MA; Pirovano G
    AJR Am J Roentgenol; 2007 Nov; 189(5):1223-37. PubMed ID: 17954665
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Multistation whole-body high-spatial-resolution MR angiography using a 32-channel MR system.
    Nael K; Ruehm SG; Michaely HJ; Saleh R; Lee M; Laub G; Finn JP
    AJR Am J Roentgenol; 2007 Feb; 188(2):529-39. PubMed ID: 17242265
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in the assessment of the abdominal aorta and its major branches at 3 Tesla.
    Kramer U; Fenchel M; Laub G; Seeger A; Klumpp B; Bretschneider C; Finn JP; Claussen CD; Miller S
    Acad Radiol; 2010 May; 17(5):564-76. PubMed ID: 20171907
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intra-arterial MR angiography in the iliac system: initial clinical experience with 25 patients.
    Paetzel C; Zorger N; Hamer OW; Seitz J; Schleicher T; Feuerbach S; Nitz WR; Lenhart M; Herold T
    Br J Radiol; 2006 Apr; 79(940):298-302. PubMed ID: 16585721
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diagnosis of systemic arterial diseases with whole-body 3D contrast-enhanced magnetic resonance angiography.
    Lin J; Chen B; Wang JH
    Chin Med J (Engl); 2006 Nov; 119(21):1772-8. PubMed ID: 17097030
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Blood pool contrast-enhanced MRA: improved arterial visualization in the steady state.
    van Bemmel CM; Wink O; Verdonck B; Viergever MA; Niessen WJ
    IEEE Trans Med Imaging; 2003 May; 22(5):645-52. PubMed ID: 12846433
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Feasibility of peripheral contrast-enhanced magnetic resonance angiography at 3.0 Tesla with a hybrid technique: comparison with digital subtraction angiography.
    Berg F; Bangard C; Bovenschulte H; Hellmich M; Nijenhuis M; Lackner K; Gossmann A
    Invest Radiol; 2008 Sep; 43(9):642-9. PubMed ID: 18708858
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 4D phase contrast MRI at 3 T: effect of standard and blood-pool contrast agents on SNR, PC-MRA, and blood flow visualization.
    Bock J; Frydrychowicz A; Stalder AF; Bley TA; Burkhardt H; Hennig J; Markl M
    Magn Reson Med; 2010 Feb; 63(2):330-8. PubMed ID: 20024953
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Monitoring of gadolinium-BOPTA uptake into the vessel wall during magnetic resonance (MR)-guided angioplasty of the peripheral arteries with a paclitaxel/gadolinium-BOPTA-coated balloon: an experimental study at 3 Tesla.
    Neizel M; Ruebben A; Weiss N; Günther RW; Kelm M; Krombach GA
    Rofo; 2014 Apr; 186(4):388-93. PubMed ID: 24142436
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Extracardiac applications of MR blood pool contrast agent in children.
    Farmakis SG; Khanna G
    Pediatr Radiol; 2014 Dec; 44(12):1598-609; quiz 1595-7. PubMed ID: 25408135
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection.
    Krause U; Kroencke T; Spielhaupter E; Taupitz M; Kenn W; Hamm B; Hahn D
    J Magn Reson Imaging; 2005 Apr; 21(4):449-54. PubMed ID: 15778953
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Steady state vascular imaging with extracellular gadobutrol: evaluation of the additional diagnostic benefit in patients who have undergone a peripheral magnetic resonance angiography protocol.
    Ong MM; Hausotter K; Pilz LR; Schoenberg SO; Michaely HJ
    J Cardiovasc Magn Reson; 2013 Oct; 15(1):97. PubMed ID: 24156379
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Gadolinium-enhanced magnetic resonance angiography of abdominal blood vessels].
    Stehling MK; Holzknecht N; Laub G
    Radiologe; 1997 Jul; 37(7):539-46. PubMed ID: 9340687
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Multicenter, intra-individual comparison of single dose gadobenate dimeglumine and double dose gadopentetate dimeglumine for MR angiography of the peripheral arteries (the Peripheral VALUE Study).
    Wang J; Yan F; Liu J; Lu J; Li D; Luan J; Wang X; Li Y; Iezzi R; De Cobelli F
    J Magn Reson Imaging; 2013 Oct; 38(4):926-37. PubMed ID: 23371919
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluating peripheral arterial disease with unenhanced quiescent-interval single-shot MR angiography at 3 T.
    Amin P; Collins JD; Koktzoglou I; Molvar C; Markl M; Edelman RR; Carr JC
    AJR Am J Roentgenol; 2014 Apr; 202(4):886-93. PubMed ID: 24660721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.